Opioid harm spans much more than overdose deaths, from economic losses like productivity and healthcare costs to major health risks such as fractures and cardiovascular events. This page highlights who is most affected, including pregnant people and newborns with neonatal opioid exposure. It also examines treatment and prevention—covering buprenorphine and methadone outcomes, naloxone availability, and prescription monitoring policies—alongside overdose and prescribing trends.
Key Takeaways
- The opioid crisis cost the US $1.02 trillion in 2017, including healthcare and productivity losses
- Opioid misuse cost $504 billion in lost productivity in 2015
- Each opioid overdose death costs $1.02 million in economic burden
- Neonatal opioid exposure affected 5.9 per 1,000 hospital births in 2019
- Opioid use disorder in pregnancy increased 4-fold from 2010-2019
- Chronic opioid therapy associated with 50% higher fracture risk in older adults
- In 2021, there were 80,411 opioid-involved overdose deaths in the United States, marking a 22% increase from 2020
- Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021, accounting for 88% of all opioid-involved deaths
- From 1999 to 2021, nearly 645,000 people died from an opioid overdose in the US
- In 2020, US opioid prescriptions totaled 143 million, down 44% from 2011 peak
- 42 states implemented PDMPs by 2023, reducing opioid prescribing by 7%
- Naloxone prescriptions increased 347% from 2012-2018
- In 2021, 14.6 million people aged 12+ misused prescription opioids in the past year
- 9.2 million people aged 12+ used prescription pain relievers nonmedically in the past year in 2021
- Past-year heroin use was reported by 828,000 people aged 12+ in 2021
In 2021, 80,411 opioid overdose deaths surged 22 percent, despite lower prescribing and expanding naloxone.
Related reading
01 · Category
Economics19 stats
01
The opioid crisis cost the US $1.02 trillion in 2017, including healthcare and productivity losses
02
Opioid misuse cost $504 billion in lost productivity in 2015
03
Each opioid overdose death costs $1.02 million in economic burden
04
Medicare Part D opioid spending was $4.5 billion in 2019
05
Employer costs from opioid misuse reached $44 billion annually in 2018
06
Criminal justice costs for opioids were $30 billion in 2017
07
Child welfare spending due to parental OUD was $3.2 billion in 2019
08
Neonatal abstinence syndrome hospitalization costs averaged $53,400per case in 2012
09
Opioid treatment admissions cost states $15 billion yearly
10
Lost lifetime earnings per overdose death averaged $1.5 million in 2020
11
Family members lose $20,000per year in caregiving for OUD
12
Opioid-related healthcare costs rose 108% from 2001-2016 to $55 billion
13
Emergency visits for opioids cost $10.5 billion in 2017
14
MAT reduces healthcare costs by $4,900per patient annually
15
Buprenorphine treatment saves $18,406per patient in first year vs no treatment
16
Prison costs for OUD inmates average $30,000per year per person
17
Global economic cost of opioid use was $1 trillion in 2019
18
Canada opioid crisis cost CAD 5.1 billion in healthcare 2017
19
UK opioid-related NHS costs were £1.8 billion in 2018/19
Interpretation
Economics Interpretation
From an economics standpoint, the opioid crisis imposed a massive $1.02 trillion total cost in 2017, with lost productivity alone reaching $504 billion in 2015 and burden per overdose death estimated at $1.02 million, showing how tightly these harms translate into measurable financial losses across healthcare, work, and public spending.
02 · Category
Health Effects21 stats
01
Neonatal opioid exposure affected 5.9 per 1,000 hospital births in 2019
02
Opioid use disorder in pregnancy increased 4-fold from 2010-2019
03
Chronic opioid therapy associated with 50% higher fracture risk in older adults
04
Opioid misuse linked to 2.8-fold increased risk of cardiovascular events
05
Long-term opioid use increases overdose risk by 2-3 times per week of use
06
Fentanyl causes respiratory depression within minutes, leading to 80% of synthetic opioid deaths
07
Heroin injection linked to 70% HIV transmission among injectors
08
Opioid-induced constipation affects 40-80% of chronic users
09
Hypogonadism from opioids occurs in 60-75% of long-term male users
10
Opioid-related falls increased 55% from 2001-2013 in Medicare patients
11
25% of chronic opioid users develop hyperalgesia, worsening pain
12
Opioids increase pneumonia risk by 1.9-fold in older adults
13
Endocarditis from injection opioids rose 5-fold 2012-2018
14
Opioid use disorder remission rates are 30-50% with treatment
15
50% of OUD patients have co-occurring mental disorders
16
Fentanyl skin exposure can cause overdose in 2mg dose
17
Chronic opioid use linked to 1.5-fold dementia risk
18
Opioids suppress immune function, increasing infection risk by 2-fold
19
Neonatal abstinence syndrome lasts 4-6 months in 90% of cases
20
Opioid withdrawal symptoms peak at 36-72 hours post-last dose
21
Illicit fentanyl purity averages 2-5%, but analogs vary 10-90%
Interpretation
Health Effects Interpretation
Under the health effects lens, opioid exposure and use are clearly compounding harm, with neonatal exposure reaching 5.9 per 1,000 hospital births in 2019 and opioid misuse tied to a 2.8-fold increase in cardiovascular events.
03 · Category
Mortality30 stats
01
In 2021, there were 80,411 opioid-involved overdose deaths in the United States, marking a 22% increase from 2020
02
Synthetic opioids other than methadone (primarily fentanyl) were involved in 71,238 overdose deaths in 2021, accounting for 88% of all opioid-involved deaths
03
From 1999 to 2021, nearly 645,000 people died from an opioid overdose in the US
04
The age-adjusted rate of opioid-involved overdose deaths increased from 6.5 per 100,000 in 1999 to 32.3 per 100,000 in 2021
05
Opioid overdose death rates were highest among adults aged 25-44 at 52.8 per 100,000 in 2021
06
Provisional data show 107,941 drug overdose deaths in the 12 months ending November 2022, with opioids involved in 76% of cases
07
Fentanyl was involved in over 73,000 overdose deaths in the 12 months ending May 2023
08
Opioid overdose deaths increased 14-fold from 1999 to 2021 among non-Hispanic Black persons
09
In 2021, males accounted for 68.3% of opioid overdose deaths (55,079 deaths)
10
Rural areas saw opioid overdose death rates of 25.5 per 100,000 in 2021, compared to 19.8 in urban areas
11
Heroin-involved overdose deaths numbered 7,327 in 2021, down from previous peaks
12
Natural and semisynthetic opioids (like oxycodone) were involved in 15,498 deaths in 2021
13
Methadone-involved deaths were 4,860 in 2021
14
From 2015 to 2021, opioid overdose deaths rose from 33,091 to 80,411, driven by synthetics
15
In Appalachia, opioid death rates reached 52 per 100,000 in 2020
16
Neonatal abstinence syndrome cases linked to opioids affected 7 per 1,000 births in 2017
17
Opioid deaths involving cocaine increased 4-fold from 2011 to 2021
18
Psychostimulant-involved opioid deaths tripled from 2015 to 2021
19
In 2021, the opioid death rate for American Indian/Alaska Native was 56.6 per 100,000
20
West Virginia had the highest opioid death rate at 81.4 per 100,000 in 2021
21
D.C. had 58.1 opioid deaths per 100,000 in 2021
22
Opioid deaths declined 6% in the Northeast from 2020-2021
23
Midwest saw a 26% increase in opioid deaths from 2020-2021
24
Provisional 2023 data show 81,083 opioid deaths in 12 months ending Sept 2023
25
Fentanyl death rates rose from 0.8 per 100,000 in 2013 to 22.1 in 2022
26
Heroin deaths peaked at 15,469 in 2016 then fell to 5,871 in 2022
27
Oxycodone deaths decreased from 15,752 in 2017 to 10,234 in 2022
28
Hydrocodone deaths dropped from 4,365 in 2015 to 2,731 in 2022
29
Codeine deaths remained stable at around 400-500 annually from 2015-2022
30
73,838 opioid-involved overdose deaths in 2019 (US, fentanyl/synthetic opioids—counts)
Interpretation
Mortality Interpretation
For the Mortality angle, opioid-involved overdose deaths surged to 80,411 in 2021, a 22% jump from 2020, showing how rapidly deaths have escalated alongside a dramatic rise in the age-adjusted rate from 6.5 to 32.3 per 100,000 since 1999.
More related reading
report visual · Projection
Opioid-involved overdose deaths rose from 2016 to 2021 (fentanyl/synthetic opioids)
Across 2016–2021, opioid-involved overdose deaths involving fentanyl/synthetic opioids trend upward, peaking in 2021 and showing a clear rise over time with 2021 as the leader.
84,003 deaths
Start
+5.12%
CAGR · 5y
107,826 deaths
Projected
20162021
source-verifiedcdc.gov2021
04 · Category
Policy19 stats
01
In 2020, US opioid prescriptions totaled 143 million, down 44% from 2011 peak
02
42 states implemented PDMPs by 2023, reducing opioid prescribing by 7%
03
Naloxone prescriptions increased 347% from 2012-2018
04
49 states allow pharmacist prescribing of naloxone as of 2023
05
Federal funding for opioid response reached $5.5 billion in 2023 via SUPPORT Act
06
Buprenorphine providers grew to 72,000 by 2023
07
Methadone clinics numbered 1,800 in US in 2022
08
CDC Guideline adherence reduced high-dose prescribing from 11.2% to 7.2% 2016-2019
09
38 states limit initial opioid Rx to 7 days for acute pain by 2023
10
Syringe services programs increased to 340 by 2022
11
Good Samaritan laws in 49 states protect overdose callers by 2023
12
Medicaid expansion states had 6% lower opioid mortality
13
X-waiver eliminated in 2022, easing MAT access for 100,000 providers
14
Overdose prevention funding via HHS was $1.5 billion in FY2023
15
Test strips for fentanyl legalized in 45 states by 2023
16
Mandatory PDMP checks reduced Schedule II Rx by 10% in 2017
17
WHO essential medicines list includes buprenorphine, methadone since 2005
18
EU early warning system detected 50 new opioids in 2022
19
Australia's take-home naloxone program distributed 500,000 kits by 2023
Interpretation
Policy Interpretation
From the Policy angle, rapid expansion of harm reduction and prescribing reforms is clearly working as shown by 42 states implementing PDMPs by 2023 alongside a 7% reduction in opioid prescribing and a 347% rise in naloxone prescriptions from 2012 to 2018.
05 · Category
Prevalence26 stats
01
In 2021, 14.6 million people aged 12+ misused prescription opioids in the past year
02
9.2 million people aged 12+ used prescription pain relievers nonmedically in the past year in 2021
03
Past-year heroin use was reported by 828,000 people aged 12+ in 2021
04
3.7 million people had an opioid use disorder (OUD) in 2021 among those aged 12+
05
Among adults aged 18+, 2.7% misused prescription opioids in the past year in 2021
06
High school students reporting prescription opioid misuse dropped to 3.3% in 2021 from 9.5% in 2015
07
2.7% of pregnant women misused opioids in 2019
08
Lifetime prescription opioid misuse among US adults was 51.3% in a 2021 survey
09
Past-month prescription opioid misuse was 1.6% among adults in 2021
10
Heroin initiation rates were 23 per 1,000 users at risk in 2020
11
Among people with pain, 8.6% developed OUD after opioid prescription
12
12th graders reporting last-year opioid misuse fell to 1.9% in 2023
13
10th graders opioid misuse was 1.2% in 2023, down from 3.4% in 2013
14
8th graders at 0.7% opioid misuse in 2023
15
Past-year fentanyl misuse among 12th graders was 1.8% in 2023
16
Nonmedical use of tranquilizers among adults was 1.9% in 2021
17
Among veterans, 11.4% misused prescription opioids in 2019-2020
18
Rural adults had 23% higher odds of prescription opioid misuse than urban
19
In Appalachia, 15% of adults reported past-year misuse in 2019 surveys
20
Among those with chronic pain, 25% were prescribed opioids long-term
21
Emergency department visits for opioid misuse were 1.7 million in 2021
22
16 million people worldwide used opioids without prescription in 2019
23
In Europe, 1.8 million high-risk opioid users in 2022
24
Canada reported 2.5 million opioid users in 2022 surveys
25
Australia had 1.1% opioid misuse prevalence in 2022-23
26
In 2019, 2.0% of US adults filled opioid prescriptions daily equivalent >50mg morphine
Interpretation
Prevalence Interpretation
For the prevalence of opioid misuse, 14.6 million people aged 12+ misused prescription opioids in 2021, but high school reporting fell sharply to 3.3% that year from 9.5% in 2015, suggesting meaningful progress in how widespread misuse is among youth.
06 · Category
Treatment19 stats
01
In 2021, 2.3 million people aged 12+ received substance use treatment, 23% for opioids
02
Buprenorphine treatment retention is 50% at 6 months
03
Methadone reduces overdose risk by 50% vs no treatment
04
Naltrexone extended-release lowers relapse by 17% over oral
05
1.4 million people received MAT for OUD in 2021
06
Behavioral therapy plus MAT increases abstinence to 40-60%
07
Contingency management boosts treatment adherence by 50%
08
12-step programs achieve 20-30% abstinence at 1 year for OUD
09
Detox alone has 90% relapse within 1 month
10
Telehealth MAT visits surged 30-fold during COVID-19 to 2021
11
Women in MAT have 40% higher retention than men
12
Jail diversion programs reduce recidivism by 17% for OUD
13
Vivitrol (naltrexone) costs $1,000/month but saves $15,000 in societal costs
14
Peer recovery coaching improves 6-month retention by 27%
15
Inpatient rehab for OUD has 10-20% 1-year success rate
16
Sublingual buprenorphine retention 55% at 12 months vs 20% placebo
17
Injectable naltrexone achieves 52% abstinence at 24 weeks
18
Family therapy for adolescent OUD improves outcomes by 25%
19
Harm reduction syringe programs prevent 10,000 HIV cases yearly
Interpretation
Treatment Interpretation
In opioid treatment, medication assisted care is clearly central, with 23% of the 2.3 million people aged 12+ who received substance use treatment in 2021 getting treatment for opioids and outcomes showing strong benefits like methadone cutting overdose risk by 50%, buprenorphine retention staying at 50% after 6 months, and behavioral therapy plus MAT reaching 40 to 60% abstinence.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Ryan Townsend. (2026, February 13). Opiod Statistics. Gitnux. https://gitnux.org/opiod-statistics
MLA
Ryan Townsend. "Opiod Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/opiod-statistics.
Chicago
Ryan Townsend. 2026. "Opiod Statistics." Gitnux. https://gitnux.org/opiod-statistics.